Suppression of tumor growth by intra-muscular transfer of naked DNA encoding adrenomedullin antagonist

12Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We have recently reported that the intra-tumoral injection of adrenomedullin (AM) antagonist (AMA; AM (22-52)) peptides significantly reduced the in vivo growth of a pancreatic cancer cell line in severely combined immunodeficient (SCID) mice. In the present study, we examined the effects of intra-tumoral and intra-muscular transfers of naked DNA encoding AMA on the in vivo growth of cancer cell lines. We demonstrate that these treatments induce the regression of a pancreatic cancer cell line and a breast cancer cell line inoculated in SCID mice. Furthermore, CD31-positive cells disappear completely from tumor tissues, following treatment, indicating that neo-vascularization is entirely inhibited. These results suggest that the intra-tumoral or intra-muscular transfer of naked DNA encoding AMA might be a promising alternative modality for treating human cancers. © 2007 Nature Publishing Group All rights reserved.

Cite

CITATION STYLE

APA

Miseki, T., Kawakami, H., Natsuizaka, M., Darmanin, S., Cui, H. Y., Chen, J., … Kobayashi, M. (2007). Suppression of tumor growth by intra-muscular transfer of naked DNA encoding adrenomedullin antagonist. Cancer Gene Therapy, 14(1), 39–44. https://doi.org/10.1038/sj.cgt.7700979

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free